BALDUZZI, Sara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.822
EU - Europa 2.842
AS - Asia 2.590
SA - Sud America 414
Continente sconosciuto - Info sul continente non disponibili 87
AF - Africa 69
OC - Oceania 6
Totale 12.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.615
GB - Regno Unito 931
SG - Singapore 783
CN - Cina 587
IT - Italia 587
HK - Hong Kong 317
BR - Brasile 312
VN - Vietnam 304
SE - Svezia 267
DE - Germania 219
IE - Irlanda 172
BD - Bangladesh 156
FI - Finlandia 123
FR - Francia 110
CA - Canada 109
RU - Federazione Russa 98
UA - Ucraina 90
IN - India 70
KR - Corea 67
TR - Turchia 54
ID - Indonesia 53
NL - Olanda 42
MX - Messico 37
BG - Bulgaria 36
AR - Argentina 35
JP - Giappone 35
BE - Belgio 24
ZA - Sudafrica 23
PL - Polonia 22
PK - Pakistan 19
CL - Cile 16
ES - Italia 16
AT - Austria 15
IQ - Iraq 15
PH - Filippine 15
CR - Costa Rica 14
MY - Malesia 13
AE - Emirati Arabi Uniti 12
CO - Colombia 12
EC - Ecuador 12
GR - Grecia 12
LT - Lituania 12
JM - Giamaica 10
VE - Venezuela 10
JO - Giordania 9
MA - Marocco 9
MK - Macedonia 9
NP - Nepal 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
KE - Kenya 8
CH - Svizzera 7
HN - Honduras 7
IL - Israele 7
TH - Thailandia 7
AU - Australia 6
DK - Danimarca 6
PE - Perù 6
BH - Bahrain 5
BO - Bolivia 5
CY - Cipro 5
DZ - Algeria 5
IR - Iran 5
NO - Norvegia 5
OM - Oman 5
PT - Portogallo 5
PY - Paraguay 5
RO - Romania 5
TN - Tunisia 5
MD - Moldavia 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
PR - Porto Rico 3
SN - Senegal 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BB - Barbados 2
BW - Botswana 2
CW - ???statistics.table.value.countryCode.CW??? 2
GP - Guadalupe 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
Totale 12.719
Salva come PNG Salva come JPEG
Città #
Ashburn 738
Southend 661
Fairfield 582
Singapore 534
Santa Clara 522
Woodbridge 330
Chandler 311
Hong Kong 309
San Jose 308
Houston 237
Seattle 219
Council Bluffs 208
Ann Arbor 192
Wilmington 178
Dublin 171
Beijing 167
Dearborn 163
Cambridge 160
Nyköping 147
Jacksonville 127
Chicago 115
New York 111
London 107
Los Angeles 104
Hefei 103
Hanoi 93
The Dalles 90
Helsinki 86
Ho Chi Minh City 84
Modena 76
Dallas 68
San Diego 55
Milan 54
Seoul 49
Columbus 44
Bologna 40
Jakarta 39
Shanghai 39
Boardman 38
Lauterbourg 37
Munich 37
Princeton 35
Rome 35
São Paulo 35
Moscow 34
Sofia 34
Buffalo 32
Eugene 32
Phoenix 31
Redwood City 30
Toronto 30
Salt Lake City 29
Elk Grove Village 23
Frankfurt am Main 23
Tampa 23
Izmir 22
Atlanta 21
Tokyo 21
Brussels 20
Montreal 20
Orem 20
Bremen 19
Turin 19
Warsaw 19
Fremont 18
San Francisco 18
Mexico City 16
Sterling 14
Brooklyn 13
Dong Ket 13
Norwalk 13
Haiphong 11
Newark 11
North Bergen 11
Ottawa 11
Cleveland 10
Miami 10
Paris 10
Philadelphia 10
Redondo Beach 10
Reggio Emilia 10
San José 10
Chennai 9
Denver 9
Hillsboro 9
Seongnam 9
Turku 9
Charlotte 8
Da Nang 8
Istanbul 8
Las Vegas 8
Rio de Janeiro 8
Tilburg 8
Amman 7
Amsterdam 7
Biên Hòa 7
Boston 7
Brasília 7
Buenos Aires 7
Des Moines 7
Totale 8.701
Salva come PNG Salva come JPEG
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 529
Non-steroid agents for idiopathic pulmonary fibrosis 524
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 461
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 436
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 436
Short-term and long-term effects of tibolone in postmenopausal women 429
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 421
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 414
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 403
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 399
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 387
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 378
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 374
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 367
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 356
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 337
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 330
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 326
Trastuzumab containing regimens for early breast cancer. 318
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 314
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 312
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 312
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 309
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 305
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 301
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 293
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 292
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 291
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 287
Short and long term effects of tibolone in postmenopausal women 279
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 263
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 263
Trastuzumab-containing regimens for metastatic breast cancer 248
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 236
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 217
Erlotinib for advanced pancreatic cancer 201
Outpatient parents' views on shared-decision-making at an Italian children's hospital 174
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 167
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial. 78
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial. 63
Totale 12.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022629 0 0 0 43 27 49 33 57 91 82 157 90
2022/20231.033 95 123 72 92 94 100 26 94 261 13 18 45
2023/2024622 21 28 46 53 103 59 80 63 23 39 43 64
2024/20251.858 57 25 38 110 371 321 148 117 170 76 179 246
2025/20263.832 235 101 260 377 654 244 518 202 369 390 308 174
2026/20271.068 167 232 248 421 0 0 0 0 0 0 0 0
Totale 12.830